Human Vaccines & Immunotherapeutics, Volume 8, Issue 4 (2012)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Human Vaccines & Immunotherapeutics, Volume 8, Issue 4 (2012)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Volume 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editor's Corner

Editorial
Letter from the Editor
Ronald W. Ellis & Eva M. Riedmann
Page: 415
Published online: 01 Apr 2012
CitationforLetter from the Editor | PDF (100.3 KB)
  • 116 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

News, Policy & Profiles

News
News
Eva M. Riedmann
Pages: 416-419
Published online: 01 Apr 2012
AbstractforNews | PDF (150.3 KB)
  • 228 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Portrait of a Leading Vaccinologist

Editorial
A lucky career in bacterial vaccines
Porter W. Anderson
Pages: 420-422
Published online: 01 Apr 2012
First Page PreviewforA lucky career in bacterial vaccines | PDF (219.3 KB)
  • 296 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Case Report

Case Report
Cutaneous necrotic ulceration due to BCG re-vaccination
Mette Gyldenløve, Åse Bengård Andersen & Liselotte Brydensholt Halkjær
Pages: 423-424
Published online: 28 Feb 2012
AbstractforCutaneous necrotic ulceration due to BCG re-vaccination | PDF (242.2 KB)
  • 988 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge
Anwar Hashem, Bozena Jaentschke, Caroline Gravel, Monika Tocchi, Tracey Doyle, Michael Rosu-Myles, Runtao He & Xuguang Li
Pages: 425-430
Published online: 28 Feb 2012
AbstractforSubcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge | PDF (409.7 KB) | Supplemental
  • 601 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Brief Report
Evaluation of the HPV 18 antibody response in Gardasil® vaccinees after 48 mo using a pseudovirion neutralization assay
Christine Roberts, Ryan Swoyer & Janine Bryan
Pages: 431-434
Published online: 16 Feb 2012
AbstractforEvaluation of the HPV 18 antibody response in Gardasil® vaccinees after 48 mo using a pseudovirion neutralization assay | Full Text | References | PDF (174.7 KB)
  • 796 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Mtb9.9 protein family
An immunodominant antigen family of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice
Chao Peng, Lu Zhang, Dan Liu, Wenxi Xu, Kewei Hao, Zhenling Cui & Honghai Wang
Pages: 435-442
Published online: 28 Feb 2012
AbstractforMtb9.9 protein family | Full Text | References | PDF (1.2 MB)
  • 721 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Pandemic influenza hospitalization in Spain (2009): Incidence, in-hospital mortality, comorbidities and costs
Cristina Rodríguez-Rieiro, Pilar Carrasco-Garrido, Valentín Hernández-Barrera , Ana López de Andrés, Isabel Jimenez-Trujillo, Angel Gil de Miguel & Rodrigo Jiménez-García
Pages: 443-447
Published online: 28 Feb 2012
AbstractforPandemic influenza hospitalization in Spain (2009): Incidence, in-hospital mortality, comorbidities and costs | PDF (221 KB)
  • 512 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Article
Hepatitis B vaccination failure in children with Diabetes Mellitus? The debate continues
Salvatore Leonardi, Giovanna Vitaliti, Maria Teresa Garozzo, Michele Miraglia del Giudice, Gianluigi Marseglia & Mario La Rosa
Pages: 448-452
Published online: 28 Feb 2012
AbstractforHepatitis B vaccination failure in children with Diabetes Mellitus? The debate continues | Full Text | References | PDF (207 KB)
  • 1341 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Article
Formulation development of a plant-derived h1n1 influenza vaccine containing purified recombinant hemagglutinin antigen
Vidyashankara Iyer, Mangala Roshan Liyanage, Yoko Shoji, Jessica A. Chichester, R. Mark Jones, Vidadi Yusibov, Sangeeta B. Joshi & C. Russell Middaugh
Pages: 453-464
Published online: 28 Feb 2012
AbstractforFormulation development of a plant-derived h1n1 influenza vaccine containing purified recombinant hemagglutinin antigen | Full Text | References | PDF (1.4 MB) | Supplemental
  • 1457 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia
Hiie Soeorg, Eda Tamm, Kristi Huik, Merit Pauskar, Dagmar Mägi, Kristiine Pruudel, Lehi Vainomäe, Leelo Moosar, Kaisa Kirss, Siiri Torm, Margit Närska, Aime Pütsepp, Helke Nurm, Kaie Pruunsild, Ave Jänes, Kai Zilmer & Irja Lutsar
Pages: 465-469
Published online: 28 Feb 2012
AbstractforGroup A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia | Full Text | References | PDF (257.6 KB)
  • 765 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen
Thomas Shin, Panyupa Pankhong, Jian Yan, Amir S Khan, Niranjan Y Sardesai & David B. Weiner
Pages: 470-478
Published online: 16 Feb 2012
AbstractforInduction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen | Full Text | References | PDF (1.3 MB)
  • 1007 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Exploratory clinical studies of a synthetic HIV-1 Tat epitope vaccine in asymptomatic treatment-naïve and antiretroviral-controlled HIV-1 infected subjects plus healthy uninfected subjects
Gideon Goldstein & John Chicca
Pages: 479-485
Published online: 16 Feb 2012
AbstractforExploratory clinical studies of a synthetic HIV-1 Tat epitope vaccine in asymptomatic treatment-naïve and antiretroviral-controlled HIV-1 infected subjects plus healthy uninfected subjects | Full Text | References | PDF (682.8 KB)
  • 782 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine
Manmohan Singh, Jina Kazzaz, Mildred Ugozzoli, Barbara Baudner, Mariagrazia Pizza, Marzia Giuliani, Lynn D. Hawkins, Gillis Otten & Derek T. O’Hagan
Pages: 486-490
Published online: 01 Apr 2012
AbstractforMF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine | PDF (303.3 KB)
  • 945 Views
  • 31 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Japanese Encephalitis vaccine: Need of the hour in endemic states of India
Ramesh Verma
Pages: 491-493
Published online: 28 Feb 2012
AbstractforJapanese Encephalitis vaccine: Need of the hour in endemic states of India | PDF (187.2 KB)
  • 904 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Glycoconjugate vaccine strategies for protection against invasive Salmonella infections
Raphael Simon & Myron M. Levine
Pages: 494-498
Published online: 28 Feb 2012
AbstractforGlycoconjugate vaccine strategies for protection against invasive Salmonella infections | Full Text | References | PDF (230.2 KB)
  • 1473 Views
  • 50 CrossRef citations
  • 0Altmetric
Free Access
What counts in cytometric analysis to document vaccine immunogenicity?
Benson Ogunjimi, Viggo Van Tendeloo, Pierre Van Damme & Philippe Beutels
Pages: 499-500
Published online: 28 Feb 2012
AbstractforWhat counts in cytometric analysis to document vaccine immunogenicity? | Full Text | References | PDF (140.4 KB)
  • 418 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Rotavirus vaccine: A cost effective control measure for India
Arun Kumar, Manish Goel, RamBilas Jain, Pardeep Khanna & Vibha
Pages: 501-504
Published online: 01 Apr 2012
AbstractforRotavirus vaccine: A cost effective control measure for India | PDF (205.4 KB)
  • 464 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Editor's Corner

Editorial
Two years of Provenge
Eva M. Riedmann
Page: 505
Published online: 01 Apr 2012
CitationforTwo years of Provenge | PDF (112.8 KB)
  • 338 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Special Focus Review

Review Article
Pharmaco-economic aspects of Sipuleucel-T
Steven Simoens
Pages: 506-508
Published online: 16 Feb 2012
AbstractforPharmaco-economic aspects of Sipuleucel-T | Full Text | References | PDF (175.5 KB)
  • 1211 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Sipuleucel-T for the treatment of metastatic prostate cancer
Promise and challenges
Channing J. Paller & Emmanuel S. Antonarakis
Pages: 509-519
Published online: 01 Apr 2012
AbstractforSipuleucel-T for the treatment of metastatic prostate cancer | Full Text | References | PDF (366.9 KB)
  • 1284 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Review Article
An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer
Johnna Wesley, James Whitmore, James Trager & Nadeem Sheikh
Pages: 520-527
Published online: 28 Feb 2012
AbstractforAn overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer | Full Text | References | PDF (1.1 MB)
  • 1865 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Blood cells and their use in active immunotherapy of prostate cancer
Shuang Yin Zhang, Eddie Thara, David Quinn & Tanya Dorff
Pages: 528-533
Published online: 28 Feb 2012
AbstractforBlood cells and their use in active immunotherapy of prostate cancer | Full Text | References | PDF (223.7 KB)
  • 535 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
Thomas Gardner, Bennett Elzey & Noah M. Hahn
Pages: 534-539
Published online: 01 Apr 2012
AbstractforSipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer | Full Text | References | PDF (507.2 KB)
  • 4201 Views
  • 66 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Comment on “Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years”
Abdul Rehman Zia Zaidi et al.
Letter to the Editor | Published online: 18 Jul 2024
Open Access
Rejoinder to comments on ‘‘Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China’’
Floriano Amimo
Letter to the Editor | Published online: 18 Jul 2024
Open Access
Effectiveness of influenza vaccine among the population in Chongqing, China, 2018–2022: A test negative design-based evaluation
Shuang Yang et al.
Article | Published online: 18 Jul 2024
Open Access
Human vaccines and immunotherapeutics: News June 2024
Ronald Ellis et al.
Editorial | Published online: 18 Jul 2024
Open Access